Ken Fisher Ultragenyx Pharmaceutical Inc. Transaction History
Fisher Asset Management, LLC
- $247 Billion
- Q2 2025
A detailed history of Ken Fisher (Fisher Asset Management, LLC) transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Fisher Asset Management, LLC holds 185,756 shares of RARE stock, worth $5.22 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
185,756
Previous 207,755
10.59%
Holding current value
$5.22 Million
Previous $7.52 Million
10.21%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding RARE
# of Institutions
330Shares Held
89.3MCall Options Held
1.05MPut Options Held
1.01M-
Vanguard Group Inc Valley Forge, PA10.2MShares$287 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$158 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA3.94MShares$111 Million0.43% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.22MShares$90.5 Million0.01% of portfolio
-
State Street Corp Boston, MA2.62MShares$73.6 Million0.0% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $1.97B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...